Are homocysteine and MTHFR genotype polymorphism associated with arteriovenous fistula patency? [2] (multiple letters)

American Journal of Kidney Diseases

Volumn 46, Issue 5, 2005, Pages 993-994

  Tai, Hsin Chieh ^a   Yang, Wu Chang ^a   Chen, Tzen Wen ^a   Lin, Chih Ching ^a   Mallamaci, Francesca ^b   Tripepi, Giovanni ^b   Zoccali, Carmine ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); C REACTIVE PROTEIN; CHOLESTEROL; FOLIC ACID; HOMOCYSTEINE; RIBOFLAVIN;

ACCURACY; ARTERIOVENOUS FISTULA; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DNA POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LETTER; PREDICTION; PROTEIN BLOOD LEVEL; RISK FACTOR; VASCULAR PATENCY; VEIN THROMBOSIS; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 27144453588     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.08.027     Document Type: Letter

References (2)

1. F. Mallamaci G. Bonanno G. Seminara Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients Am J Kidney Dis 45 2005 702 707
2. M. Den Heijer S. Lewington R. Clarke Homocysteine, MTHFR and risk of venous thrombosis A meta-analysis of published epidemiological studies J Thromb Haemost 3 2005 292–269